3 Dec 2021
Tryp Therapeutics to Present at the H.C. Wainwright Psychedelics Conference on December 6, 2021
Author: admintech | Filed under: Press ReleaseSAN DIEGO, Dec. 3, 2021 /PRNewswire/ — Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (“Tryp or the “Company”), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs, announced today that it will present at the 2nd Annual H.C….